MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions

Journal of Neuroimmunology

Volumn 246, Issue 1-2, 2012, Pages 27-33

  Lescher, Juliane ^a   Paap, Franziska ^a   Schultz, Verena ^a   Redenbach, Laura ^a   Scheidt, Uta ^a   Rosewich, Hendrik ^a   Nessler, Stefan ^a   Fuchs, Eberhard ^b   Gärtner, Jutta ^a   Brück, Wolfgang ^a   Junker, Andreas ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

Author keywords

EAE; Marmoset; MicroRNA; MiRNA 146a b; MiRNA 155; Multiple sclerosis

Indexed keywords

MICRORNA; MICRORNA 125A 5P; MICRORNA 132; MICRORNA 135B; MICRORNA 142 3P; MICRORNA 146A; MICRORNA 146B; MICRORNA 155; MICRORNA 184; MICRORNA 19A; MICRORNA 21; MICRORNA 23A; MICRORNA 326; MICRORNA 34A; MICRORNA 491; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN TISSUE; C57BL 6 MOUSE; CALLITRICHINAE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETIC REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPINAL CORD; UPREGULATION;

ANIMALS; CALLITHRIX; DOWN-REGULATION; HUMANS; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; MICRORNAS; MULTIPLE SCLEROSIS; UP-REGULATION;

EID: 84860196299     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.02.012     Document Type: Article

References (64)

1. Aronica E., Fluiter K., Iyer A., et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 2010, 31:1100-1107.
2. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
3. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. (Berl.) 1997, 75:165-173.
4. Breij E.C., Brink B.P., Veerhuis R., et al. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 2008, 63:16-25.
5. Cardoso A.L., Guedes J.R., de Almeida L.P., Pedroso de Lima M.C. miR-155 modulates microglia-mediated immune response by downregulating SOCS-1 and promoting cytokine and NO production. Immunology 2011, 10-2567.
6. Coolen M., Bally-Cuif L. MicroRNAs in brain development and physiology. Curr. Opin. Neurobiol. 2009, 19:461-470.
7. Cox M.B., Cairns M.J., Gandhi K.S., et al. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 2010, 5:e12132.
8. Cui J.G., Li Y.Y., Zhao Y., Bhattacharjee S., Lukiw W.J. Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J. Biol. Chem. 2010, 285:38951-38960.
9. Czech M.P. MicroRNAs as therapeutic targets. N. Engl. J. Med. 2006, 354:1194-1195.
10. De Santis G., Ferracin M., Biondani A., et al. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J. Neuroimmunol. 2010, 226:165-171.
11. Diem R., Demmer I., Boretius S., et al. Autoimmune optic neuritis in the common marmoset monkey: comparison of visual evoked potentials with MRI and histopathology. Investig. Ophthalmol. Vis. Sci. 2008, 49:3707-3714.
12. Du C., Liu C., Kang J., et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009, 10:1252-1259.
13. Eisele S., Krumbholz M., Fischer M.T., et al. Prospects of transcript profiling for mRNAs and microRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions. Brain Pathol. 2012, Epub ahead of print, 10-3639.
14. Elmen J., Lindow M., Schutz S., et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.
15. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28:138-145.
16. + cell activation in patients with multiple sclerosis. Neurosci. Lett. 2011, 504:9-12.
17. Guerau-de-Arellano M., Smith K.M., Godlewski J., et al. Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain. 2011, 134:3578-3589.
18. Habelhah H., Frew I.J., Laine A., et al. Stress-induced decrease in TRAF2 stability is mediated by Siah2. EMBO J. 2002, 21:5756-5765.
19. Hu W., Lucchinetti C.F. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin. Immunopathol. 2009, 31:439-453.
20. Junker A. Pathophysiology of translational regulation by microRNAs in multiple sclerosis. FEBS Lett. 2011, 585:3738-3746.
21. Junker A., Krumbholz M., Eisele S., et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009, 132:3342-3352.
22. Junker A., Hohlfeld R., Meinl E. The emerging role of microRNAs in multiple sclerosis. Nat. Rev. Neurol. 2011, 7:56-59.
23. Keller A., Leidinger P., Lange J., et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009, 4:e7440.
24. Kosik K.S. The neuronal microRNA system. Nat. Rev. Neurosci. 2006, 7:911-920.
25. Krishnamoorthy G., Wekerle H. EAE: an immunologist's magic eye. Eur. J. Immunol. 2009, 39:2031-2035.
26. Krutzfeldt J., Rajewsky N., Braich R., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
27. Kuhlmann T., Lingfeld G., Bitsch A., Schuchardt J., Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002, 125:2202-2212.
28. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
29. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
30. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
31. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
32. + lymphocytes of relapsing-remitting multiple sclerosis patients. Eur. J. Immunol. 2010, 40:888-898.
33. Liston A., Lu L.F., O'Carroll D., Tarakhovsky A., Rudensky A.Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 2008, 205:1993-2004.
34. Lodish H.F., Zhou B., Liu G., Chen C.Z. Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 2008, 8:120-130.
35. Lu L.F., Boldin M.P., Chaudhry A., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010, 142:914-929.
36. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999, 122:2279-2295.
37. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
38. Lukiw W.J., Zhao Y., Cui J.G. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 2008, 283:31315-31322.
39. Martinelli-Boneschi F., Fenoglio C., Brambilla P., et al. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci. Lett. 2012, 508:4-8.
40. Merkler D., Boscke R., Schmelting B., et al. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey. Brain Pathol. 2006, 16:117-123.
41. Merkler D., Schmelting B., Czeh B., Fuchs E., Stadelmann C., Bruck W. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions. Mult. Scler. 2006, 12:369-374.
42. Monticelli S., Ansel K.M., Xiao C., et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol. 2005, 6:R71.
43. Mor E., Cabilly Y., Goldshmit Y., et al. Species-specific microRNA roles elucidated following astrocyte activation. Nucleic Acids Res. 2011, 39:3710-3723.
44. Murugaiyan G., Beynon V., Mittal A., Joller N., Weiner H.L. Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 2011, 187:2213-2221.
45. Ng E.K., Chong W.W., Jin H., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
46. Noorbakhsh F., Ellestad K.K., Maingat F., et al. Impaired neurosteroid synthesis in multiple sclerosis. Brain 2011, 134:2703-2721.
47. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343:938-952.
48. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1604-1609.
49. O'Connell R.M., Kahn D., Gibson W.S., et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010, 33:607-619.
50. O'Connell R.M., Rao D.S., Chaudhuri A.A., Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 2010, 10:111-122.
51. Otaegui D., Baranzini S.E., Armananzas R., et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009, 4:e6309.
52. Platten M., Steinman L. Multiple sclerosis: trapped in deadly glue. Nat. Med. 2005, 11:252-253.
53. Ponomarev E.D., Veremeyko T., Barteneva N., Krichevsky A.M., Weiner H.L. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat. Med. 2011, 17:64-70.
54. Rusca N., Monticelli S. MiR-146a in immunity and disease. Mol. Biol. Int. 2011, 437301. Epub; 2011 Apr 7., 437301.
55. Saxena A., Martin-Blondel G., Mars L.T., Liblau R.S. Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis. FEBS Lett. 2011, 585:3758-3763.
56. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
57. Sriram S., Rodriguez M. Indictment of the microglia as the villain in multiple sclerosis. Neurology 1997, 48:464-470.
58. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12481-12486.
59. Taganov K.D., Boldin M.P., Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007, 26:133-137.
60. Thamilarasan M., Koczan D., Hecker M., Paap B., Zettl U.K. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Autoimmun. Rev. 2012, 11:174-179.
61. Tili E., Michaille J.J., Cimino A., et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 2007, 179:5082-5089.
62. Waschbisch A., Atiya M., Linker R.A., Potapov S., Schwab S., Derfuss T. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS One 2011, 6:e24604.
63. Wust S., van den Brandt J., Tischner D., et al. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J. Immunol. 2008, 180:8434-8443.
64. Zhou X., Jeker L.T., Fife B.T., et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 2008, 205:1983-1991.